SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-20-285914
Filing Date
2020-11-05
Accepted
2020-11-04 21:58:29
Documents
3
Effectiveness Date
2020-11-05

Document Format Files

Seq Description Document Type Size
1 8-K d44097d8k.htm DEFA14A 19550
2 EX-99.1 d44097dex991.htm EX-99.1 15798
3 GRAPHIC g44097g1105074936135.jpg GRAPHIC 4954
  Complete submission text file 0001193125-20-285914.txt   43471
Mailing Address 28159 AVENUE STANFORD SUITE 220 VALENCIA CA 91355
Business Address 28159 AVENUE STANFORD SUITE 220 VALENCIA CA 91355 661-367-9170
Avita Therapeutics, Inc. (Filer) CIK: 0001762303 (see all company filings)

IRS No.: 202578762 | State of Incorp.: DE | Fiscal Year End: 0630
Type: DEFA14A | Act: 34 | File No.: 001-39059 | Film No.: 201288445
SIC: 3841 Surgical & Medical Instruments & Apparatus